Nifty

:

15699.25

Sensex

:

52727.98

142.60 (0.92%)
462.26 (0.88%)

Login

Nifty
Sensex

:
:

15699.25
52727.98

142.60 (0.92%)
462.26 (0.88%)

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

40/99

BSE: 500288 | NSE: MOREPENLAB

Watchlist

NSE BSE

35.60

24-Jun-2022

Day's Open
Day's High
Day's Low
Previous Close

35.50
36.40
35.25
35.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

463980
165.99
75.00
32.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,777.04
17.48
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,726.19
N/A
2.56

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.17
14.81
15.63

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.94
14.07
11.91

PAT CAGR (%)

10 Years
5 Years
3 Years

-
32.66
49.86

P:E (Median)

8 Years
5 Years
3 Years

31.05
26.53
21.79

P:BV (Average)

8 Years
5 Years
3 Years

4.53
4.43
4.00

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.36
14.81
13.29

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 342.44 264.11 29.66% 372.21 290.46 28.15% 369.39 314.60 17.42% 365.23 243.26 50.14%
Expenses 323.26 236.45 36.71% 341.72 260.34 31.26% 332.56 285.27 16.58% 322.59 217.98 47.99%
EBITDA 19.18 27.65 -30.63% 30.49 30.12 1.23% 36.83 29.33 25.57% 42.64 25.27 68.74%
EBIDTM 5.60% 10.47% 8.19% 10.37% 9.97% 9.32% 11.68% 10.39%
Other Income 3.11 3.87 -19.64% 2.69 2.84 -5.28% 2.85 3.73 -23.59% 1.58 1.33 18.80%
Interest 0.80 -0.05 - 0.75 1.27 -40.94% -9.12 0.29 - 0.21 0.29 -27.59%
Depreciation 4.82 6.43 -25.04% 5.28 7.05 -25.11% 5.70 7.15 -20.28% 5.40 7.47 -27.71%
PBT 16.67 25.14 -33.69% 27.15 24.64 10.19% 43.10 25.62 68.23% 38.62 18.84 104.99%
Tax 2.40 0.00 0 5.64 0.00 0 8.67 0.00 0 7.77 0.00 0
PAT 14.28 25.14 -43.20% 21.51 24.64 -12.70% 34.43 25.62 34.39% 30.85 18.84 63.75%
PATM 4.17% 9.52% 5.78% 8.48% 9.32% 8.14% 8.45% 7.75%
EPS 0.30 0.53 -43.40% 0.45 0.52 -13.46% 0.72 0.54 33.33% 0.65 0.39 66.67%

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 368.28 286.60 28.50% 396.50 307.42 28.98% 395.31 336.39 17.52% 386.73 257.64 50.10%
Expenses 349.61 256.20 36.46% 364.38 277.63 31.25% 353.29 304.64 15.97% 342.88 231.07 48.39%
EBITDA 18.67 30.40 -38.59% 32.12 29.79 7.82% 42.03 31.75 32.38% 43.85 26.57 65.04%
EBIDTM 5.07% 10.61% 8.10% 9.69% 10.63% 9.44% 11.34% 10.31%
Other Income 3.18 4.16 -23.56% 2.69 2.84 -5.28% 2.85 3.73 -23.59% 1.58 1.33 18.80%
Interest 0.80 -0.05 - 0.75 1.27 -40.94% -9.12 0.29 - 0.21 0.29 -27.59%
Depreciation 6.88 6.98 -1.43% 6.93 7.56 -8.33% 7.14 7.68 -7.03% 6.69 8.06 -17.00%
PBT 14.17 27.64 -48.73% 27.14 23.80 14.03% 46.86 27.52 70.28% 38.53 19.55 97.08%
Tax 1.85 0.87 112.64% 5.62 0.01 56,100.00% 9.50 0.35 2,614.29% 8.06 0.19 4,142.11%
PAT 12.32 26.76 -53.96% 21.52 23.79 -9.54% 37.36 27.17 37.50% 30.47 19.37 57.31%
PATM 3.35% 9.34% 5.43% 7.74% 9.45% 8.08% 7.88% 7.52%
EPS 0.26 0.59 -55.93% 0.48 0.53 -9.43% 0.83 0.60 38.33% 0.68 0.43 58.14%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 1,449.27 1,112.42 791.99 717.24 560.83 547.51 452.46 370.26 335.97 303.35 269.50 Net Sales Growth 30.28% 40.46% 10.42% 27.89% 2.43% 21.01% 22.20% 10.21% 10.75% 12.56% Cost Of Goods Sold 990.55 691.36 487.87 448.98 335.30 328.24 273.04 223.63 194.39 185.79 172.43 Gross Profit 458.72 421.06 304.13 268.26 225.52 219.27 179.42 146.64 141.58 117.56 97.07 GP Margin 31.65% 37.85% 38.40% 37.40% 40.21% 40.05% 39.65% 39.60% 42.14% 38.75% 36.02% Total Expenditure 1,320.13 1,000.05 727.52 652.22 500.56 487.02 388.26 323.68 290.16 274.37 251.87 Power & Fuel Cost - 13.00 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 % Of Sales - 1.17% 1.59% 1.84% 1.98% 1.80% 1.69% 2.00% 2.51% 2.95% 3.64% Employee Cost - 123.20 98.07 84.74 68.22 60.79 51.67 43.52 39.16 34.47 32.12 % Of Sales - 11.07% 12.38% 11.81% 12.16% 11.10% 11.42% 11.75% 11.66% 11.36% 11.92% Manufacturing Exp. - 66.82 48.90 31.27 16.21 15.05 13.33 12.63 12.23 11.33 11.34 % Of Sales - 6.01% 6.17% 4.36% 2.89% 2.75% 2.95% 3.41% 3.64% 3.73% 4.21% General & Admin Exp. - 29.69 31.93 31.21 24.35 21.53 15.34 13.77 14.60 11.43 12.18 % Of Sales - 2.67% 4.03% 4.35% 4.34% 3.93% 3.39% 3.72% 4.35% 3.77% 4.52% Selling & Distn. Exp. - 44.09 35.75 31.72 29.13 29.04 19.87 16.06 15.11 15.48 10.51 % Of Sales - 3.96% 4.51% 4.42% 5.19% 5.30% 4.39% 4.34% 4.50% 5.10% 3.90% Miscellaneous Exp. - 31.89 12.45 11.11 16.26 22.53 7.38 6.66 6.25 6.91 10.51 % Of Sales - 2.87% 1.57% 1.55% 2.90% 4.11% 1.63% 1.80% 1.86% 2.28% 1.29% EBITDA 129.14 112.37 64.47 65.02 60.27 60.49 64.20 46.58 45.81 28.98 17.63 EBITDA Margin 8.91% 10.10% 8.14% 9.07% 10.75% 11.05% 14.19% 12.58% 13.64% 9.55% 6.54% Other Income 10.23 11.77 9.42 3.67 3.54 3.72 1.17 1.36 0.79 2.62 1.02 Interest -7.36 1.79 1.97 2.07 4.29 7.47 10.41 8.63 9.89 11.61 7.96 Depreciation 21.20 28.11 34.43 38.01 33.40 33.56 34.92 38.59 45.77 45.74 46.89 PBT 125.54 94.25 37.48 28.61 26.12 23.17 20.04 0.72 -9.06 -25.75 -36.20 Tax 24.48 0.00 5.15 0.00 0.00 0.00 -0.14 0.14 0.00 0.00 0.00 Tax Rate 19.50% 0.00% 13.74% 0.00% 0.00% 0.00% -0.90% 19.44% 0.00% 0.00% 0.00% PAT 101.07 94.25 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 PAT before Minority Interest 101.07 94.25 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.97% 8.47% 4.08% 3.99% 4.66% 4.23% 3.49% 0.16% -1.83% -7.47% -8.96% PAT Growth 7.25% 191.52% 13.00% 9.53% 12.73% 46.83% 2,620.69% - - - EPS 2.12 1.97 0.68 0.60 0.55 0.48 0.33 0.01 -0.13 -0.47 -0.51

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 1,546.82 1,188.06 853.07 768.54 606.51 595.47 485.08 400.64 366.85 325.92 289.34 Net Sales Growth 30.20% 39.27% 11.00% 26.72% 1.85% 22.76% 21.08% 9.21% 12.56% 12.64% Cost Of Goods Sold 1,049.31 735.29 524.19 479.12 361.28 358.35 293.33 238.62 209.04 193.53 178.07 Gross Profit 497.51 452.77 328.87 289.42 245.23 237.12 191.76 162.02 157.81 132.39 111.27 GP Margin 32.16% 38.11% 38.55% 37.66% 40.43% 39.82% 39.53% 40.44% 43.02% 40.62% 38.46% Total Expenditure 1,410.16 1,069.54 784.55 701.02 541.78 534.09 423.52 352.41 317.95 294.97 270.11 Power & Fuel Cost - 13.00 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 % Of Sales - 1.09% 1.47% 1.71% 1.83% 1.65% 1.57% 1.85% 2.30% 2.75% 3.39% Employee Cost - 135.59 109.91 95.36 76.53 69.69 58.29 48.79 45.08 39.17 36.05 % Of Sales - 11.41% 12.88% 12.41% 12.62% 11.70% 12.02% 12.18% 12.29% 12.02% 12.46% Manufacturing Exp. - 67.21 48.92 31.28 16.21 22.36 13.33 12.68 12.23 11.33 10.20 % Of Sales - 5.66% 5.73% 4.07% 2.67% 3.76% 2.75% 3.16% 3.33% 3.48% 3.53% General & Admin Exp. - 34.71 36.47 36.14 28.52 18.11 18.14 15.89 16.62 13.86 14.37 % Of Sales - 2.92% 4.28% 4.70% 4.70% 3.04% 3.74% 3.97% 4.53% 4.25% 4.97% Selling & Distn. Exp. - 49.66 40.11 32.73 30.04 25.79 23.45 21.40 19.55 20.40 15.85 % Of Sales - 4.18% 4.70% 4.26% 4.95% 4.33% 4.83% 5.34% 5.33% 6.26% 5.48% Miscellaneous Exp. - 34.08 12.39 13.20 18.11 29.95 9.35 7.61 7.01 7.72 15.85 % Of Sales - 2.87% 1.45% 1.72% 2.99% 5.03% 1.93% 1.90% 1.91% 2.37% 1.99% EBITDA 136.67 118.52 68.52 67.52 64.73 61.38 61.56 48.23 48.90 30.95 19.23 EBITDA Margin 8.84% 9.98% 8.03% 8.79% 10.67% 10.31% 12.69% 12.04% 13.33% 9.50% 6.65% Other Income 10.30 12.07 9.48 3.67 3.72 3.72 1.20 1.37 1.22 2.87 1.18 Interest -7.36 1.79 1.98 2.11 4.36 7.56 10.50 8.66 9.92 11.63 7.96 Depreciation 27.64 30.28 36.91 39.90 34.32 33.90 35.20 38.67 45.84 45.80 48.06 PBT 126.70 98.51 39.11 29.18 29.77 23.63 17.06 2.28 -5.64 -23.61 -35.61 Tax 25.03 1.42 5.53 0.34 0.00 0.00 -0.13 0.14 0.01 -0.01 0.06 Tax Rate 19.76% 1.44% 14.14% 1.17% 0.00% 0.00% -1.03% 6.14% -0.36% 0.05% -0.25% PAT 101.67 97.09 33.58 28.85 29.59 23.63 12.80 2.14 -2.77 -20.52 -23.65 PAT before Minority Interest 101.67 97.09 33.58 28.84 29.77 23.63 12.80 2.14 -2.75 -20.52 -23.63 Minority Interest 0.00 0.00 0.00 0.01 -0.18 0.00 0.00 0.00 -0.02 0.00 -0.02 PAT Margin 6.57% 8.17% 3.94% 3.75% 4.88% 3.97% 2.64% 0.53% -0.76% -6.30% -8.17% PAT Growth 4.72% 189.13% 16.40% -2.50% 25.22% 84.61% 498.13% - - - EPS 2.13 2.03 0.70 0.60 0.62 0.49 0.27 0.04 -0.06 -0.43 -0.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 444.97 307.25 277.46 250.56 224.34 328.85 313.08 324.26 330.42 353.09 Share Capital 89.96 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 Total Reserves 311.26 217.29 187.50 160.60 134.38 119.24 103.47 114.65 120.81 143.48 Non-Current Liabilities 26.89 25.36 21.11 17.87 15.28 55.22 72.69 84.05 103.36 121.93 Secured Loans 0.83 0.92 1.79 2.70 0.94 42.74 62.22 74.65 94.49 98.85 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 Long Term Provisions 24.01 22.38 17.85 13.45 12.69 10.71 8.71 7.35 6.78 5.60 Current Liabilities 375.63 329.38 320.82 322.21 308.19 150.78 114.44 99.58 107.72 107.69 Trade Payables 192.33 158.38 157.08 164.89 116.20 107.48 78.55 66.75 54.90 63.59 Other Current Liabilities 164.37 157.39 153.61 156.05 190.70 39.14 32.82 30.91 52.14 43.20 Short Term Borrowings 15.32 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 Short Term Provisions 3.60 2.25 1.14 1.26 1.29 4.16 0.84 0.73 0.68 0.90 Total Liabilities 847.49 661.99 619.39 590.64 547.81 534.85 500.21 507.89 541.50 582.71 Net Block 144.02 134.84 152.59 182.10 191.29 216.36 243.93 289.47 330.91 373.57 Gross Block 516.17 641.54 777.14 890.30 922.26 914.18 907.16 902.43 898.34 895.47 Accumulated Depreciation 372.14 506.70 624.55 708.20 730.96 697.82 663.23 612.96 567.43 521.90 Non Current Assets 354.71 313.73 336.06 363.54 369.25 387.98 395.80 415.92 454.30 496.93 Capital Work in Progress 1.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 118.78 118.78 117.69 117.69 117.69 117.69 117.94 117.94 121.81 121.81 Long Term Loans & Adv. 89.67 59.83 65.49 63.47 59.41 53.92 33.93 8.51 1.58 1.55 Other Non Current Assets 0.27 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 Current Assets 492.79 348.26 283.33 227.11 178.56 146.88 104.41 91.97 87.20 85.78 Current Investments 0.00 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 169.61 132.47 90.84 73.94 62.50 40.82 35.36 32.91 36.75 38.01 Sundry Debtors 155.52 121.41 121.96 110.22 83.10 80.35 48.45 40.09 36.59 33.13 Cash & Bank 66.98 38.03 31.98 5.70 6.75 3.63 8.60 8.07 4.72 3.96 Other Current Assets 100.68 5.90 7.72 5.49 26.22 22.08 12.00 10.90 9.14 10.68 Short Term Loans & Adv. 90.88 50.45 30.80 31.53 21.67 16.27 8.89 7.94 6.56 9.00 Net Current Assets 117.16 18.88 -37.49 -95.10 -129.63 -3.91 -10.03 -7.61 -20.52 -21.91 Total Assets 847.50 661.99 619.39 590.65 547.81 534.86 500.21 507.89 541.50 582.71

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 424.75 284.06 253.09 225.94 196.26 300.28 287.48 297.11 299.88 320.40 Share Capital 89.96 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 Total Reserves 291.04 194.10 163.13 135.98 106.30 90.67 77.87 87.50 90.27 110.79 Non-Current Liabilities 30.06 28.42 23.38 20.20 17.80 57.47 74.00 84.65 103.91 122.05 Secured Loans 0.83 0.92 1.83 2.95 1.38 43.41 62.27 74.78 94.65 98.85 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 Long Term Provisions 25.39 23.82 19.01 14.42 13.59 11.34 9.22 7.82 7.17 5.73 Current Liabilities 403.80 351.44 339.17 340.12 324.86 166.56 127.92 108.14 102.73 104.95 Trade Payables 208.85 172.30 168.15 174.88 124.88 115.33 84.96 68.60 56.81 64.98 Other Current Liabilities 174.38 165.06 160.64 163.90 198.65 47.04 39.87 37.58 45.22 38.96 Short Term Borrowings 15.32 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 Short Term Provisions 5.25 2.72 1.39 1.33 1.33 4.19 0.86 0.77 0.70 1.01 Total Liabilities 858.15 663.46 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 Net Block 224.52 216.37 236.21 264.29 271.80 296.72 322.48 368.08 409.46 451.86 Gross Block 628.32 752.55 887.76 997.60 1,026.96 1,018.43 1,009.35 1,004.61 1,000.44 997.38 Accumulated Depreciation 403.79 536.18 651.55 733.31 755.15 721.72 686.87 636.53 590.98 545.52 Non Current Assets 331.36 291.29 315.71 342.37 346.34 366.53 374.42 393.18 415.00 457.37 Capital Work in Progress 1.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 1.08 1.08 0.00 0.00 0.00 0.00 0.00 0.00 3.87 3.87 Long Term Loans & Adv. 103.52 73.55 79.22 77.81 73.69 69.82 51.94 25.10 1.67 1.64 Other Non Current Assets 0.27 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 Current Assets 526.79 372.18 299.47 243.44 191.95 157.15 114.58 96.32 91.09 89.61 Current Investments 0.00 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 175.33 138.48 94.20 76.89 64.66 42.14 37.11 33.30 37.05 38.66 Sundry Debtors 181.98 137.68 133.75 121.85 92.95 87.94 56.14 42.67 39.11 35.15 Cash & Bank 67.89 38.88 32.21 5.95 7.59 4.36 8.85 9.11 5.53 4.51 Other Current Assets 101.59 5.98 7.86 5.62 26.74 22.71 12.48 11.24 9.40 11.29 Short Term Loans & Adv. 91.58 51.16 31.43 32.92 22.03 16.77 9.34 8.23 6.23 9.60 Net Current Assets 122.99 20.73 -39.70 -96.68 -132.92 -9.41 -13.34 -11.82 -11.64 -15.34 Total Assets 858.15 663.47 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 49.31 10.86 14.58 61.25 49.24 50.01 50.74 33.19 33.46 26.77 PBT 94.25 37.48 28.61 26.12 22.55 20.04 0.72 -9.06 -25.75 -36.20 Adjustment 29.63 34.23 38.36 37.86 40.92 45.32 47.22 55.66 56.73 54.84 Changes in Working Capital -74.56 -55.33 -52.40 -2.72 -14.23 -11.09 2.94 -16.31 -0.60 -3.91 Cash after chg. in Working capital 49.31 16.38 14.58 61.25 49.24 54.27 50.88 30.29 30.38 14.73 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 -5.52 0.00 0.00 0.00 0.14 -0.14 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 -4.40 0.00 2.90 3.08 12.04 Cash From Investing Activity -69.09 -12.08 -10.34 -24.28 -14.67 -27.08 -30.22 -0.65 -2.51 -3.34 Net Fixed Assets 123.41 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 Net Investments 0.00 -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 Others -192.50 -146.61 -123.70 -56.02 -6.59 -20.31 -25.49 -0.43 0.36 -4.04 Cash from Financing Activity 47.46 4.65 -0.35 -37.67 -31.29 -27.89 -19.99 -29.19 -30.19 -21.81 Net Cash Inflow / Outflow 27.68 3.43 3.89 -0.69 3.29 -4.97 0.53 3.35 0.76 1.62 Opening Cash & Equivalents 12.79 9.36 5.47 6.16 2.87 8.60 8.07 4.72 3.96 2.34 Closing Cash & Equivalent 40.47 12.79 9.36 5.47 6.16 3.63 8.60 8.07 4.72 3.96

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 50.83 11.02 17.37 63.41 40.73 50.07 50.70 33.52 33.64 27.11 PBT 98.51 39.11 29.18 29.77 23.04 17.06 2.28 -5.64 -23.60 -35.61 Adjustment 31.96 36.63 40.32 38.64 41.40 45.69 47.32 55.76 56.80 55.99 Changes in Working Capital -78.18 -58.84 -51.78 -5.00 -23.72 -8.41 1.23 -19.50 -2.64 -5.25 Cash after chg. in Working capital 52.29 16.89 17.71 63.41 40.73 54.34 50.83 30.62 30.56 15.13 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.46 -5.88 -0.34 0.00 0.00 0.13 -0.13 0.01 0.01 -0.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 -4.40 0.00 0.00 0.00 0.00 Cash From Investing Activity -70.35 -12.46 -13.05 -26.93 -13.60 -27.30 -31.65 -0.80 -2.83 -3.35 Net Fixed Assets 123.41 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 Net Investments 0.00 -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 Others -193.76 -146.99 -126.41 -58.67 -5.52 -20.53 -26.92 -0.58 0.04 -4.05 Cash from Financing Activity 47.27 5.49 -0.44 -37.77 -23.72 -27.26 -19.31 -29.14 -29.79 -21.83 Net Cash Inflow / Outflow 27.75 4.04 3.88 -1.29 3.40 -4.49 -0.26 3.58 1.02 1.93 Opening Cash & Equivalents 13.64 9.60 5.72 7.00 3.60 8.85 9.11 5.53 4.51 2.58 Closing Cash & Equivalent 41.39 13.64 9.60 5.72 7.00 4.36 8.85 9.11 5.53 4.51

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 8.92 6.83 6.17 5.57 4.99 4.65 4.30 4.55 4.69 5.19 ROA 12.49% 5.05% 4.73% 4.59% 4.28% 3.05% 0.12% -1.17% -4.03% -4.03% ROE 26.61% 11.06% 10.84% 11.00% 10.69% 7.84% 0.29% -2.97% -10.21% -9.84% ROCE 24.54% 10.82% 7.74% 9.26% 9.17% 6.60% 2.32% 0.87% -2.42% -3.29% Fixed Asset Turnover 1.92 1.12 0.86 0.62 0.60 0.51 0.42 0.38 0.34 0.31 Receivable days 45.43 56.08 59.08 62.91 54.48 50.93 42.76 41.07 41.14 40.65 Inventory Days 49.56 51.46 41.93 44.40 34.44 30.13 32.97 37.31 44.11 47.84 Payable days 92.58 79.07 88.97 104.24 84.35 83.75 77.64 70.84 71.22 76.97 Cash Conversion Cycle 2.41 28.47 12.04 3.07 4.58 -2.69 -1.90 7.54 14.02 11.52 Total Debt/Equity 0.04 0.04 0.47 0.53 0.22 0.20 0.26 0.27 0.34 0.34 Interest Cover 53.71 20.05 14.82 7.08 4.10 2.50 1.08 0.38 -0.95 -2.04

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 8.47 6.32 5.63 5.02 4.36 4.02 3.73 3.95 4.01 4.46 ROA 12.76% 5.25% 4.80% 5.30% 4.45% 2.53% 0.44% -0.55% -3.90% -4.19% ROE 29.20% 12.50% 12.04% 14.10% 12.54% 7.35% 1.24% -1.54% -10.77% -11.12% ROCE 27.13% 12.05% 10.01% 14.05% 10.18% 6.29% 2.90% 1.80% -2.09% -3.40% Fixed Asset Turnover 1.72 1.04 0.82 0.60 0.58 0.49 0.41 0.37 0.33 0.29 Receivable days 49.10 58.07 60.70 64.63 55.44 53.22 44.17 40.16 40.83 40.35 Inventory Days 48.20 49.78 40.63 42.59 32.73 29.27 31.48 34.55 41.63 45.68 Payable days 94.60 79.06 88.85 103.38 82.97 83.88 76.01 67.69 69.30 75.59 Cash Conversion Cycle 2.71 28.78 12.48 3.85 5.20 -1.39 -0.36 7.02 13.16 10.44 Total Debt/Equity 0.04 0.05 0.52 0.06 0.25 0.22 0.28 0.30 0.37 0.38 Interest Cover 56.09 20.71 14.83 7.83 4.13 2.21 1.26 0.72 -0.77 -1.96

Top Investors:

pinfold overseas limited

ferry holdings limited

damodar prasad agarwal

morepen laboratories limited

Annual Reports:

News Update:

Morepen Laboratories - Quarterly Results
5th May 2022, 13:32 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback